Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-03-08 Purchase(A) |
2023-03-13 6:27 pm |
Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Co-CEO & President |
23,527,044 | $1.05 | $24,703,396 | 9,884,095 (Indirect) |
View |
| 2023-03-08 Purchase |
2023-03-08 9:31 pm |
Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Co-Chief Executive Officer |
23,527,044 | $1.05 | $24,703,396 | 33,279,364 (Indirect Direct) |
View |
| 2023-03-07 Purchase |
2023-03-08 5:24 pm |
Summit Therapeutics Inc. | SMMT | Dhingra Ankur Chief Financial Officer |
196,362 | $1.05 | $206,180 | 274,085 (Indirect Direct) |
View |
| 2022-08-16 Purchase(A) |
2023-03-08 4:58 pm |
Summit Therapeutics Inc. | SMMT | Dhingra Ankur Chief Financial Officer |
37,685 | $0.97 | $36,554 | 77,723 (Indirect Direct) |
View |
| 2023-03-06 Purchase |
2023-03-08 4:12 pm |
Summit Therapeutics Inc. | SMMT | DUGGAN ROBERT W Chief Executive Officer |
376,489,880 | $1.05 | $395,314,374 | 552,354,161 (Direct) |
View |
| 2022-08-16 Purchase |
2022-08-18 4:38 pm |
Summit Therapeutics Inc. | SMMT | DUGGAN ROBERT W Chief Executive Officer |
94,849,203 | $0.97 | $92,003,727 | 162,532,792 (Direct) |
View |
| 2022-08-16 Purchase |
2022-08-18 4:36 pm |
Summit Therapeutics Inc. | SMMT | Zanganeh Maky Co-CEO & President |
5,809,132 | $0.97 | $5,634,858 | 3,495,435 (Indirect Direct) |
View |
| 2022-08-16 Purchase |
2022-08-17 4:49 pm |
Summit Therapeutics Inc. | SMMT | Dhingra Ankur Chief Financial Officer |
36,215 | $0.97 | $35,129 | 76,253 (Indirect Direct) |
View |
| 2021-05-12 Purchase |
2021-05-14 4:39 pm |
Summit Therapeutics Inc. | SMMT | DUGGAN ROBERT W Chief Executive Officer 10% Owner |
11,365,921 | $5.24 | $59,557,426 | 67,662,454 (Direct) |
View |
| 2021-05-12 Purchase |
2021-05-14 4:37 pm |
Summit Therapeutics Inc. | SMMT | Zanganeh Maky Chief Operating Officer |
389,077 | $5.24 | $2,038,763 | 4,747,860 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-01-03 Option Award |
2023-01-05 4:21 pm |
N/A 2033-01-03 |
Summit Therapeutics Inc. | SMMT | Booth Robert F. Director |
32,700 | $1.67 | 102,700 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:21 pm |
N/A 2033-01-03 |
Summit Therapeutics Inc. | SMMT | Booth Robert F. Director |
35,000 | $0 | 102,700 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:17 pm |
N/A 2033-01-03 |
Summit Therapeutics Inc. | SMMT | Cesano Alessandra Director |
16,350 | $1.67 | 86,350 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:17 pm |
N/A 2033-01-03 |
Summit Therapeutics Inc. | SMMT | Cesano Alessandra Director |
35,000 | $0 | 86,350 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:14 pm |
N/A 2033-01-03 |
Summit Therapeutics Inc. | SMMT | Mahatme Ujwala Director |
40,500 | $1.67 | 110,500 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:14 pm |
N/A 2033-01-03 |
Summit Therapeutics Inc. | SMMT | Mahatme Ujwala Director |
35,000 | $0 | 110,500 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:12 pm |
N/A 2033-01-03 |
Summit Therapeutics Inc. | SMMT | Clark Kenneth A Director |
44,400 | $1.67 | 114,400 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:12 pm |
N/A 2033-01-03 |
Summit Therapeutics Inc. | SMMT | Clark Kenneth A Director |
35,000 | $0 | 114,400 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:09 pm |
N/A 2033-01-03 |
Summit Therapeutics Inc. | SMMT | Soni Manmeet Singh Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2022-12-06 Other |
2022-12-09 6:22 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Co-CEO & President |
373,857 | $0 | 11,304,706 (Direct) |
View |
| 2022-12-06 Other |
2022-12-08 6:28 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | DUGGAN ROBERT W Chief Executive Officer |
9,346,434 | $0 | 181,225,660 (Direct) |
View |
| 2022-11-15 Option Award |
2022-11-17 4:27 pm |
N/A 2032-11-15 |
Summit Therapeutics Inc. | SMMT | Cesano Alessandra Director |
204,166 | $0 | 404,166 (Direct) |
View |
| 2022-09-28 Option Award |
2022-10-03 4:50 pm |
N/A 2032-09-28 |
Summit Therapeutics Inc. | SMMT | Booth Robert F. Director |
206,250 | $0 | 406,250 (Direct) |
View |
Ownership |
2022-06-02 5:38 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | Dhingra Ankur Chief Financial Officer |
0 | $0 | 40,038 (Direct) |
View |
| 2022-05-31 Option Award |
2022-06-02 5:29 pm |
N/A 2032-05-31 |
Summit Therapeutics Inc. | SMMT | Dhingra Ankur Chief Financial Officer |
600,000 | $0 | 600,000 (Direct) |
View |
| 2022-05-23 Other |
2022-05-25 8:45 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | DUGGAN ROBERT W Chief Executive Officer |
21,135 | $0 | 67,704,724 (Direct) |
View |
| 2022-04-25 Option Award |
2022-04-26 4:36 pm |
N/A 2032-04-25 |
Summit Therapeutics Inc. | SMMT | Gayko Urte Director |
400,000 | $0 | 400,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 4:07 pm |
N/A 2032-01-03 |
Summit Therapeutics Inc. | SMMT | Gayko Urte Director |
42,553 | $1.13 | 92,553 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 4:07 pm |
N/A 2032-01-03 |
Summit Therapeutics Inc. | SMMT | Gayko Urte Director |
25,000 | $0 | 92,553 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 4:05 pm |
N/A 2032-01-03 |
Summit Therapeutics Inc. | SMMT | Mahatme Ujwala Director |
47,872 | $1.13 | 97,872 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 4:05 pm |
N/A 2032-01-03 |
Summit Therapeutics Inc. | SMMT | Mahatme Ujwala Director |
25,000 | $0 | 97,872 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 4:03 pm |
N/A 2032-01-03 |
Summit Therapeutics Inc. | SMMT | Soni Manmeet Singh Director |
82,446 | $1.13 | 132,446 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 4:03 pm |
N/A 2032-01-03 |
Summit Therapeutics Inc. | SMMT | Soni Manmeet Singh Director |
25,000 | $0 | 132,446 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 4:01 pm |
N/A 2032-01-03 |
Summit Therapeutics Inc. | SMMT | Clark Kenneth A Director |
58,510 | $1.13 | 108,510 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 4:01 pm |
N/A 2032-01-03 |
Summit Therapeutics Inc. | SMMT | Clark Kenneth A Director |
25,000 | $0 | 108,510 (Direct) |
View |
| 2021-12-15 Option Award |
2021-12-17 4:16 pm |
N/A 2031-12-15 |
Summit Therapeutics Inc. | SMMT | Zanganeh Maky Chief Operating Officer |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-12-15 Option Award |
2021-12-17 4:09 pm |
N/A 2031-12-15 |
Summit Therapeutics Inc. | SMMT | Maranian Jeffrey R VP Corporate Controller |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-11-03 Option Award |
2021-11-16 5:17 pm |
N/A 2031-11-03 |
Summit Therapeutics Inc. | SMMT | Gayko Urte Director |
204,041 | $0 | 404,041 (Direct) |
View |
| 2021-11-11 Option Award |
2021-11-15 4:19 pm |
N/A 2031-11-11 |
Summit Therapeutics Inc. | SMMT | Maranian Jeffrey R VP Corporate Controller |
50,000 | $0 | 50,000 (Direct) |
View |
| 2021-10-07 Option Award |
2021-10-12 08:40 am |
N/A 2031-10-07 |
Summit Therapeutics Inc. | SMMT | Clark Kenneth A Director |
206,250 | $0 | 406,250 (Direct) |
View |
Ownership |
2021-07-09 4:44 pm |
2021-11-22 2030-11-22 |
Summit Therapeutics Inc. | SMMT | Maranian Jeffrey R VP, Corporate Controller |
0 | $0 | 245,000 (Direct) |
View |
| 2021-02-26 Option Award |
2021-03-02 5:36 pm |
N/A 2031-02-26 |
Summit Therapeutics Inc. | SMMT | Wang Luhua Director |
91,096 | $6.77 | 161,096 (Direct) |
View |